BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Novo Holdings at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Novo Holdings takes part in 1 session at BIO-Europe 2026 in Cologne. Its session looks at where the respiratory market goes beyond the inhaler, alongside Chiesi, Vicore Pharma and Claris Ventures.

OrganizationBIO-Europe 2026 Attendance
Novo Holdings
Hellerup, Denmark
Investors & finance
Life-science investment company that manages the Novo Nordisk Foundation's assets, investing in companies from early-stage biotech to mature healthcare businesses.
Panel
Wed Nov 11
09:00–09:45
Beyond the inhaler: The respiratory market
New drugs and targets for asthma, chronic obstructive lung disease and pulmonary fibrosis, and where investors and partners are now putting money.
with Claris Ventures, Chiesi, Vicore Pharma

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Novo Holdings

Tell us what you sell and we’ll find the people at Novo Holdings most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction